Haibo Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Venues

Cell death & disease

MedComm

This page only lists publications with an associated author ORCID identifier.

Publications

Ruiqi Liu, Yanwei Lu, Jing Li, Weiping Yao, Jiajun Wu, Xiaoyan Chen, Luanluan Huang, Ding Nan, Yitian Zhang, Weijun Chen, Ying Wang, Yongshi Jia, Jianming Tang, Xiaodong Liang, Haibo Zhang
Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway. Cell death & disease 15 (4) (2024)
Ruiqi Liu, Yanwei Lu, Jing Li, Weiping Yao, Jiajun Wu, Xiaoyan Chen, Luanluan Huang, Ding Nan, Yitian Zhang, Weijun Chen, Ying Wang, Yongshi Jia, Jianming Tang, Xiaodong Liang, Haibo Zhang
Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway. Cell death & disease 15 (4) (2024)
Ruiqi Liu, Yanwei Lu, Jing Li, Weiping Yao, Jiajun Wu, Xiaoyan Chen, Luanluan Huang, Ding Nan, Yitian Zhang, Weijun Chen, Ying Wang, Yongshi Jia, Jianming Tang, Xiaodong Liang, Haibo Zhang
Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway. Cell death & disease 15 (4) (2024)
Ruiqi Liu, Yanwei Lu, Jing Li, Weiping Yao, Jiajun Wu, Xiaoyan Chen, Luanluan Huang, Ding Nan, Yitian Zhang, Weijun Chen, Ying Wang, Yongshi Jia, Jianming Tang, Xiaodong Liang, Haibo Zhang
Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway. Cell death & disease 15 (4) (2024)
Ruiqi Liu, Jiajun Wu, Haiwei Guo, Weiping Yao, Shuang Li, Yanwei Lu, Yongshi Jia, Xiaodong Liang, Jianming Tang, Haibo Zhang
Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. MedComm 4 (3) (2023)

Haibo Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Haibo Zhang